However, the current study found no significant difference in the expression of immunotherapy-related molecules PD-1/PD-L1 or CTLA-4 between the low HPS and high HPS group, which suggested that high HPS might not directly promote immunosuppression by altering expression of ICI-related molecules. This evidence concerns the gene CTLA4 and Hermansky-Pudlak syndrome.